Nucleoside reverse-transcriptase inhibitor use, cirrhosis, and end-stage liver disease in HIV-infected patients.
Remtulla
Rahim A
RA
Decker
Catherine F
CF
D019380:Anti-HIV Agents / Q000009:adverse effects*; D005234:Fatty Liver / Q000175:diagnosis / Q000209:etiology*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D017093:Liver Failure / Q000175:diagnosis / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D012307:Risk Factors; D013997:Time Factors
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors